Valuation: Amgen Inc.

Market Cap 25TCr 23TCr 21TCr 19TCr 36TCr 23,59400Cr 37TCr 2,49000Cr 99TCr 12,64100Cr 94TCr 92TCr 39,96200Cr P/E 2026 *
24x
P/E 2027 * 23.1x
Enterprise Value 29TCr 26TCr 24TCr 22TCr 41TCr 27,25800Cr 42TCr 2,87700Cr 1,14600Cr 14,60400Cr 1,09100Cr 1,06800Cr 46,16600Cr EV / Sales 2026 *
7.37x
EV / Sales 2027 * 6.93x
Free-Float
99.77%
Yield 2026 *
2.17%
Yield 2027 * 2.29%
1 week+0.59%
Current month-0.44%
1 month+11.69%
3 months+11.33%
6 months+40.25%
Current year+38.04%
1 week 33.38
Extreme 33.38
35.3
1 month 30.48
Extreme 30.48
35.46
Current year 23.95
Extreme 23.95
35.46
1 year 23.95
Extreme 23.95
35.46
3 years 23.95
Extreme 23.95
35.46
5 years 23.95
Extreme 23.95
35.46
10 years 23.95
Extreme 23.95
35.46
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.59% - - 25TCr
+1.44%+1.63%+48.17%+139.63% 1,25800Cr
-0.47%+5.49%+49.03%+90.68% 68TCr
+0.20%+2.76%+34.37%+112.06% 52TCr
+0.17%+2.76%+44.07%+69.71% 39TCr
-0.48%+2.34%+70.66%+46.02% 37TCr
+0.76%+2.27%+31.59%+60.36% 31TCr
-1.29%+0.90%+5.77%+37.60% 29TCr
0.00%+0.86%+43.74%+74.04% 25TCr
+0.92%+2.03%+44.62%+125.07% 21TCr
Average -0.03%+1.05%+41.34%+83.91% 47TCr
Weighted average by Cap. -0.09%+1.18%+43.66%+96.83%

Financials

2026 *2027 *
Net sales 3.95TCr 3.54TCr 3.26TCr 2.96TCr 5.61TCr 3,70000Cr 5.76TCr 39TCr 16TCr 1,98200Cr 15TCr 14TCr 6,26700Cr 4.12TCr 3.7TCr 3.41TCr 3.09TCr 5.86TCr 3,86500Cr 6.02TCr 41TCr 16TCr 2,07100Cr 15TCr 15TCr 6,54700Cr
Net income 1.05TCr 944.34Cr 870.3Cr 790.38Cr 1.5TCr 99TCr 1.54TCr 10TCr 4.15TCr 53TCr 3.95TCr 3.87TCr 1,67200Cr 1.09TCr 979.37Cr 902.58Cr 819.7Cr 1.55TCr 1,02400Cr 1.59TCr 11TCr 4.31TCr 55TCr 4.1TCr 4.01TCr 1,73400Cr
Net Debt 3.91TCr 3.5TCr 3.23TCr 2.93TCr 5.55TCr 3,66300Cr 5.71TCr 39TCr 15TCr 1,96300Cr 15TCr 14TCr 6,20500Cr 3.39TCr 3.04TCr 2.8TCr 2.54TCr 4.81TCr 3,17500Cr 4.94TCr 34TCr 13TCr 1,70100Cr 13TCr 12TCr 5,37700Cr
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
10/26/10 CA$34.29 0.00% 1,506
09/26/09 CA$34.29 +0.65% 669
06/26/06 CA$34.07 +0.18% 885
05/26/05 CA$34.01 -3.46% 5,062
04/26/04 CA$35.23 +3.34% 15,111
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
465.14USD
Average target price
429.74USD
Spread / Average Target
-7.61%